dc.contributor.author | YILMAZ, C | |
dc.contributor.author | HINDILERDEN, Fehmi | |
dc.contributor.author | AKADAM-TEKER, B | |
dc.contributor.author | NALCACI, Meliha | |
dc.contributor.author | Daglar-Aday, Aynur | |
dc.contributor.author | YAVUZ, AS | |
dc.contributor.author | SARGIN, D | |
dc.contributor.author | YONAL-HINDILERDEN, I | |
dc.date.accessioned | 2021-03-04T08:03:50Z | |
dc.date.available | 2021-03-04T08:03:50Z | |
dc.identifier.citation | YONAL-HINDILERDEN I., Daglar-Aday A., HINDILERDEN F., AKADAM-TEKER B., YILMAZ C., NALCACI M., YAVUZ A., SARGIN D., "The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis.", Journal of clinical medicine research, cilt.8, ss.29-39, 2016 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_615e10e4-faa9-4da7-b412-a4110cc0762c | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/67885 | |
dc.identifier.uri | https://doi.org/10.14740/jocmr2405w | |
dc.language.iso | eng | |
dc.title | The Clinical Significance of IDH Mutations in Essential Thrombocythemia and Primary Myelofibrosis. | |
dc.type | Makale | |
dc.relation.journal | Journal of clinical medicine research | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 8 | |
dc.identifier.startpage | 29 | |
dc.identifier.endpage | 39 | |
dc.contributor.firstauthorID | 178757 | |